Investor Relations

OPKO Claros1 Analyzer Selected for Development of a Rapid Lyme Disease Test Under Immuno Technologies NIH Grant more »

OPKO Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference more »

OPKO and Pfizer Enter into Global Agreement for OPKO's Long-Acting Human Growth Hormone (hGH-CTP) more »

OPKO Health to Present at the Oppenheimer 25th Annual Healthcare Conference more »

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OPKO Health, Inc.'s financial performance into perspective.

  • Events


  • Stock Information


Ticker OPK Exchange NYSE
Last Price 11.54 Change 0.17 up
Open 11.24 Previous Close 11.37
Day High 11.59 Day Low 11.22
52-Week High 11.38 52-Week Low 7.32
Quotes delayed at least 20 minutes. Information provided by eSignal.